U.S. FDA approves AbbVie's drug for Parkinson's disease
FDA approves AbbVie’s once-daily tavapadon (Juvmo) for adults with Parkinson’s, boosting sales amid gradual Medicare coverage talks.
26 Sep 05:47 · The Hindu
last updated on 26 Sep 08:17